The American Journal of Medicine
Volume 118, Issue 11 , Pages 1262-1270 , November 2005

Impact of a general practitioner educational intervention on osteoarthritis treatment in an elderly population

  • Elham Rahme, PhD

      Affiliations

    • Department of Medicine, McGill University, Montreal, Canada
    • Research Institute, McGill University Health Center, Montreal, Canada
    • Drs. LeLorier, Choquette, Bessette and Rahme have served as consultants and paid speakers for Merck & Co. Inc. and for Pfizer Inc.
    • Dr. Rahme is a research scholar funded by The Arthritis Society.
    • Corresponding Author InformationRequests for reprints should be addressed to Elham Rahme, PhD, Division of Clinical Epidemiology, Montreal General Hospital, 1650 Cedar Ave., Montreal, Quebec H3G 1A4, Canada.
    • ,
  • Denis Choquette, MD

      Affiliations

    • Rheumatology Institute and Centre Hospitalier de l’Université de Montréal – Notre-Dame, Montreal, Canada
    • Drs. LeLorier, Choquette, Bessette and Rahme have served as consultants and paid speakers for Merck & Co. Inc. and for Pfizer Inc.
    • ,
  • Michele Beaulieu, MEd

      Affiliations

    • Merck Frosst Canada Ltd., Montreal, Canada
    • Ms. Beaulieu is an employee at Merck Frosst Canada Ltd.
    • ,
  • Louis Bessette, MD, MSc

      Affiliations

    • Rimouski Regional Hospital, Rimouski, Canada
    • Drs. LeLorier, Choquette, Bessette and Rahme have served as consultants and paid speakers for Merck & Co. Inc. and for Pfizer Inc.
    • ,
  • Lawrence Joseph, PhD

      Affiliations

    • Research Institute, McGill University Health Center, Montreal, Canada
    • Department of Epidemiology and Biostatistics, McGill University, Montreal, Canada
    • ,
  • Youssef Toubouti, MSc

      Affiliations

    • Research Institute, McGill University Health Center, Montreal, Canada
    • ,
  • Jacques LeLorier, MD, PhD (FRCPC)

      Affiliations

    • Research Centre, Centre Hospitalier de l’Université de Montréal – Hôtel-Dieu, Montreal, Canada.
    • Drs. LeLorier, Choquette, Bessette and Rahme have served as consultants and paid speakers for Merck & Co. Inc. and for Pfizer Inc.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0002-9343(05)00245-7

doi: 10.1016/j.amjmed.2005.03.026

The American Journal of Medicine
Volume 118, Issue 11 , Pages 1262-1270 , November 2005

Article Tools

* Image Usage & Resolution